Tag - pharmaceuticals

 
 

PHARMACEUTICALS

Japan Times
WORLD / Science & Health / ANALYSIS
Jun 11, 2021
U.S. FDA faces mounting criticism over Alzheimer's drug approval
The drug was authorized based on evidence that it can reduce brain plaques, a likely contributor to Alzheimer's, rather than proof that it slows progression of the disease.
Japan Times
WORLD
Jun 9, 2021
Biggest vaccine-maker’s problems keep world short of COVID-19 shots
The Serum Institute of India's travails have become a key illustration of how the effort to inoculate against COVID-19 has failed the developing world.
Japan Times
JAPAN / Science & Health
Jun 8, 2021
Changing the game for Alzheimer's treatment, U.S. approves Eisai and Biogen's drug
The approval appears to signal a fundamental shift in the way the FDA thinks about Alzheimer's disease, which could have lasting ramifications for other drugs in the pipeline.
Japan Times
BUSINESS / FOCUS
Jun 4, 2021
Chinese drugmakers take aim at lucrative U.S. anti-cancer market
In recent years, medicines that free the immune system to attack tumors have become blockbusters in a $150 billion global market.
Japan Times
WORLD / Science & Health
Jun 2, 2021
Organ transplants force patients to amass vaccinations to beat COVID-19
Research is showing that these patients are dramatically less likely to develop protective antibodies using the authorized vaccine dosage.
Japan Times
JAPAN
Jun 2, 2021
How to secure vaccines for billions? One Japanese biotech startup has an idea.
The key benefit of self-replicating vaccines is their efficiency, as they require only a fraction of the dosage of conventional vaccines to trigger a strong immune response.
Japan Times
JAPAN
May 31, 2021
Pfizer approves COVID-19 shots for 12- to 15-year-olds in Japan
The U.S. drugmaker also enabled undiluted, thawed vials of its vaccine to be stored at refrigerator temperature for a longer period of time.
Japan Times
JAPAN / Science & Health
May 28, 2021
Japan set to approve Pfizer's COVID-19 shot for 12- to 15-year-olds
The move comes after the U.S. Food and Drug Administration lowered the minimum age for the vaccine to 12 on May 10.
Japan Times
WORLD / Science & Health
May 28, 2021
AstraZeneca clot research continues amid German theory
German researchers said this week they discovered a link between the vaccine and rare blood clots.
Japan Times
ASIA PACIFIC
May 26, 2021
Taiwan says China blocked deal with BioNTech for COVID-19 shots
While Taiwan has previously said it had been unable to sign a final contract with BioNTech, it had only implied that Chinese pressure was to blame.
Japan Times
WORLD
May 26, 2021
Moderna shot effective in teens, opening path for clearances
The company said its vaccine was between 93% and 100% effective in preventing symptomatic COVID-19 in a study of teenagers.
Japan Times
JAPAN / Science & Health
May 23, 2021
Japan clinical trial of COVID-19 plasma therapy highlights slow-moving medical policy
Doctors are gearing up for clinical trials of convalescent plasma therapy, but many overseas hospitals have already moved on to other remedies.
Japan Times
JAPAN
May 21, 2021
Japan issues final approval for Moderna and AstraZeneca vaccines
The formal approvals, following a health ministry panel's sign-off Thursday, mark a major step toward speeding up the nation's sluggish inoculation drive.
Japan Times
JAPAN
May 20, 2021
Japan panel gives Moderna and AstraZeneca vaccines the green light
The approval marks an important milestone in increasing vaccine supplies as Prime Minister Yoshihide Suga aims to ramp up vaccinations to 1 million shots a day.
Japan Times
WORLD
May 20, 2021
Some vaccines help nations exit the pandemic faster than others
Evidence derived from the expanding global inoculation rollout indicates that the mRNA shots are better at stopping people from becoming contagious.
Japan Times
JAPAN
May 15, 2021
Japan risks multiple new states of emergency with slow vaccine pace, study shows
Four more states of emergency are likely at a pace of 220,000 jabs per day, while only one would be needed if 880,000 shots are given daily, scientists project.
Japan Times
WORLD / FOCUS
May 15, 2021
Big promises, few doses: Why Russia is struggling to produce Sputnik V
Putin has trumpeted the vaccine around the world, but Russia had produced just 33 million vaccines as of May 12 and exported fewer than 15 million.

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?